Nathan Lack

Dr. Nathan Lack is a senior research scientist at the Vancouver Prostate Centre and an assistant professor in the Department of Urologic Sciences at the University of British Columbia. He obtained a PhD in pharmacology from the University of Oxford in 2009 followed by a postdoctoral fellowship at the Vancouver Prostate Centre with Dr. Emma Guns and Professor Paul Rennie. Dr. Lack became an assistant professor at Koç University’s School of Medicine in 2011 and was awarded associate professorship in 2015. In addition to his academic research, he previously worked for AnorMED Inc., where he was involved in the development of the FDA-approved therapeutic Plerixafor.

Dr. Lack’s laboratory is focused on identifying and characterizing novel drug targets to treat aggressive late-stage prostate cancer by utilizing advanced functional genomics techniques in combination with classical pharmacology. In addition to extensive publications, the research from his group has identified several compounds that have been licenced and progressed to clinical development. Dr. Lack has received numerous awards for his work, including Vancouver Coast Health Research Institute’s Rising Star Award and the prestigious TÜBA-GEBIP, which is given to the best young scientists in Turkey.